Report Detail
Global Sitagliptin Sodium Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4733776 |
- 24 August, 2026 |
- Global |
- 83 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Sitagliptin Sodium market size was valued at US$ 114 million in 2025 and is forecast to a readjusted size of US$ 238 million by 2032 with a CAGR of 8.9% during review period.
In 2025, global Sitagliptin Sodium production reached approximately 580,000 units.Sitagliptin Sodium is an oral hypoglycemic agent belonging to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors, primarily used for the treatment of type 2 diabetes mellitus. It works by selectively inhibiting DPP-4 enzyme activity, thereby prolonging the action of endogenous incretins such as glucagon-like peptide-1 (GLP-1). This leads to enhanced insulin secretion and reduced glucagon release, ultimately lowering blood glucose levels. The drug is characterized by stable glucose-lowering effects, a low risk of hypoglycemia, and minimal impact on body weight. It can be used as monotherapy or in combination with other antidiabetic agents. Overall, as a well-established oral antidiabetic drug, sitagliptin sodium plays an important role in the long-term management of type 2 diabetes mellitus.
Sitagliptin Sodium, as one of the classic DPP-4 inhibitors, is primarily used in the treatment market for type 2 diabetes mellitus. With the continuous increase in the global prevalence of diabetes and the acceleration of population aging, the demand for oral hypoglycemic agents has maintained steady long-term growth, providing a solid market foundation for this drug. Owing to its high safety profile, low risk of hypoglycemia, and minimal impact on body weight, sitagliptin sodium has strong clinical reliance among elderly patients and those requiring baseline therapy, and it has long held an important position in the DPP-4 inhibitor market. From a competitive perspective, the antidiabetic drug market is becoming increasingly diversified. New classes of drugs, such as GLP-1 receptor agonists and SGLT2 inhibitors, have demonstrated advantages in glycemic control, weight reduction, and cardiovascular benefits, posing a certain substitution pressure on traditional DPP-4 inhibitors. However, due to its convenient oral administration, good tolerability, and broad applicability, sitagliptin sodium still maintains clear advantages in patients who are not suitable for injectable therapies or who require a higher safety profile.
This report is a detailed and comprehensive analysis for global Sitagliptin Sodium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Sitagliptin Sodium market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Sitagliptin Sodium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Sitagliptin Sodium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Sitagliptin Sodium market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sitagliptin Sodium
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sitagliptin Sodium market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shenzhen Chipscreen Biosciences, Chengdu Chipscreen Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Sitagliptin Sodium market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hospital
Retail
Online
Market segment by Specification
25 mg/tablet
50 mg/tablet
100 mg/tablet
Market segment by Application
Type 2 Diabetes Mellitus
Regulate Blood Lipids
Others
Major players covered
Shenzhen Chipscreen Biosciences
Chengdu Chipscreen Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sitagliptin Sodium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sitagliptin Sodium, with price, sales quantity, revenue, and global market share of Sitagliptin Sodium from 2021 to 2026.
Chapter 3, the Sitagliptin Sodium competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sitagliptin Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Sitagliptin Sodium market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sitagliptin Sodium.
Chapter 14 and 15, to describe Sitagliptin Sodium sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Sitagliptin Sodium Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Hospital
- 1.3.3 Retail
- 1.3.4 Online
- 1.4 Market Analysis by Specification
- 1.4.1 Overview: Global Sitagliptin Sodium Consumption Value by Specification: 2021 Versus 2025 Versus 2032
- 1.4.2 25 mg/tablet
- 1.4.3 50 mg/tablet
- 1.4.4 100 mg/tablet
- 1.5 Market Analysis by Application
- 1.5.1 Overview: Global Sitagliptin Sodium Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Type 2 Diabetes Mellitus
- 1.5.3 Regulate Blood Lipids
- 1.5.4 Others
- 1.6 Global Sitagliptin Sodium Market Size & Forecast
- 1.6.1 Global Sitagliptin Sodium Consumption Value (2021 & 2025 & 2032)
- 1.6.2 Global Sitagliptin Sodium Sales Quantity (2021-2032)
- 1.6.3 Global Sitagliptin Sodium Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Shenzhen Chipscreen Biosciences
- 2.1.1 Shenzhen Chipscreen Biosciences Details
- 2.1.2 Shenzhen Chipscreen Biosciences Major Business
- 2.1.3 Shenzhen Chipscreen Biosciences Sitagliptin Sodium Product and Services
- 2.1.4 Shenzhen Chipscreen Biosciences Sitagliptin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Shenzhen Chipscreen Biosciences Recent Developments/Updates
- 2.2 Chengdu Chipscreen Pharmaceutical
- 2.2.1 Chengdu Chipscreen Pharmaceutical Details
- 2.2.2 Chengdu Chipscreen Pharmaceutical Major Business
- 2.2.3 Chengdu Chipscreen Pharmaceutical Sitagliptin Sodium Product and Services
- 2.2.4 Chengdu Chipscreen Pharmaceutical Sitagliptin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Chengdu Chipscreen Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Sitagliptin Sodium by Manufacturer
- 3.1 Global Sitagliptin Sodium Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Sitagliptin Sodium Revenue by Manufacturer (2021-2026)
- 3.3 Global Sitagliptin Sodium Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Sitagliptin Sodium by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Sitagliptin Sodium Manufacturer Market Share in 2025
- 3.4.3 Top 6 Sitagliptin Sodium Manufacturer Market Share in 2025
- 3.5 Sitagliptin Sodium Market: Overall Company Footprint Analysis
- 3.5.1 Sitagliptin Sodium Market: Region Footprint
- 3.5.2 Sitagliptin Sodium Market: Company Product Type Footprint
- 3.5.3 Sitagliptin Sodium Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Sitagliptin Sodium Market Size by Region
- 4.1.1 Global Sitagliptin Sodium Sales Quantity by Region (2021-2032)
- 4.1.2 Global Sitagliptin Sodium Consumption Value by Region (2021-2032)
- 4.1.3 Global Sitagliptin Sodium Average Price by Region (2021-2032)
- 4.2 North America Sitagliptin Sodium Consumption Value (2021-2032)
- 4.3 Europe Sitagliptin Sodium Consumption Value (2021-2032)
- 4.4 Asia-Pacific Sitagliptin Sodium Consumption Value (2021-2032)
- 4.5 South America Sitagliptin Sodium Consumption Value (2021-2032)
- 4.6 Middle East & Africa Sitagliptin Sodium Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Sitagliptin Sodium Sales Quantity by Type (2021-2032)
- 5.2 Global Sitagliptin Sodium Consumption Value by Type (2021-2032)
- 5.3 Global Sitagliptin Sodium Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Sitagliptin Sodium Sales Quantity by Application (2021-2032)
- 6.2 Global Sitagliptin Sodium Consumption Value by Application (2021-2032)
- 6.3 Global Sitagliptin Sodium Average Price by Application (2021-2032)
7 North America
- 7.1 North America Sitagliptin Sodium Sales Quantity by Type (2021-2032)
- 7.2 North America Sitagliptin Sodium Sales Quantity by Application (2021-2032)
- 7.3 North America Sitagliptin Sodium Market Size by Country
- 7.3.1 North America Sitagliptin Sodium Sales Quantity by Country (2021-2032)
- 7.3.2 North America Sitagliptin Sodium Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Sitagliptin Sodium Sales Quantity by Type (2021-2032)
- 8.2 Europe Sitagliptin Sodium Sales Quantity by Application (2021-2032)
- 8.3 Europe Sitagliptin Sodium Market Size by Country
- 8.3.1 Europe Sitagliptin Sodium Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Sitagliptin Sodium Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Sitagliptin Sodium Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Sitagliptin Sodium Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Sitagliptin Sodium Market Size by Region
- 9.3.1 Asia-Pacific Sitagliptin Sodium Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Sitagliptin Sodium Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Sitagliptin Sodium Sales Quantity by Type (2021-2032)
- 10.2 South America Sitagliptin Sodium Sales Quantity by Application (2021-2032)
- 10.3 South America Sitagliptin Sodium Market Size by Country
- 10.3.1 South America Sitagliptin Sodium Sales Quantity by Country (2021-2032)
- 10.3.2 South America Sitagliptin Sodium Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Sitagliptin Sodium Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Sitagliptin Sodium Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Sitagliptin Sodium Market Size by Country
- 11.3.1 Middle East & Africa Sitagliptin Sodium Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Sitagliptin Sodium Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Sitagliptin Sodium Market Drivers
- 12.2 Sitagliptin Sodium Market Restraints
- 12.3 Sitagliptin Sodium Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Sitagliptin Sodium and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Sitagliptin Sodium
- 13.3 Sitagliptin Sodium Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Sitagliptin Sodium Typical Distributors
- 14.3 Sitagliptin Sodium Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Sitagliptin Sodium. Industry analysis & Market Report on Sitagliptin Sodium is a syndicated market report, published as Global Sitagliptin Sodium Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Sitagliptin Sodium market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
